0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models - Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA - June 27-29, 1991 (Paperback, Softcover reprint of the original 1st ed. 1994) Loot Price: R8,597
Discovery Miles 85 970
Anticancer Drug Discovery and Development: Natural Products and New Molecular Models - Proceedings of the Second Drug Discovery...

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models - Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA - June 27-29, 1991 (Paperback, Softcover reprint of the original 1st ed. 1994)

Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker

Series: Developments in Oncology, 74

 (sign in to rate)
Loot Price R8,597 Discovery Miles 85 970 | Repayment Terms: R806 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Gift Of The Givers

With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer. This Second Symposium emphasized the types of materials being discovered and their therapeutic activity. This is especially evident in the natural product discovery programs, where unique and active structures are being identified. The major contributors to the meeting were the investigators participating in the National Cooperative (Natural Products) Drug Discovery Groups [NC(NP)DDG]. These groups reflect an association among researchers at universities or cancer centers, pharmaceutical companies and the National Cancer Institute. Their sources of materials are varied, reflecting chemical inventories of pharmaceutical companies, organic synthetic compounds from the laboratory, cytotoxics as well as biologics and their hybrids, and natural products obtained from plants, marine organisms and microorganisms. The models employed in the discovery systems vary from broadly cellular based to specific enzymes to defined cellular functions. Each of them is believed important to the malignant state and will allow for the discovery of compounds which will have efficacy in cancer therapy. The goal of the participants is both to discover new anticancer agents and to develop them as efficiently as possible into clinically useful additions to treatment. Of importance is the fact that there are a number of promising leads which will soon be moving into the clinic thereby testing the effectiveness of this NC (NP) DDG approach.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Developments in Oncology, 74
Release date: October 2012
First published: 1994
Editors: Frederick A. Valeriote • Thomas H. Corbett • Laurence H. Baker
Dimensions: 235 x 155 x 21mm (L x W x T)
Format: Paperback
Pages: 403
Edition: Softcover reprint of the original 1st ed. 1994
ISBN-13: 978-1-4613-6118-3
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4613-6118-4
Barcode: 9781461361183

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners